Chart Audit
Brand Opportunities along different therapy lines
March 6, 20262.4K views
1
Objective
- Identify opportunities for Brand A in the second line, post corticosteroid patients of the rare hematological indication
- Determine factors affecting choice of therapy in second line, post corticosteroid patients
- Assess treatment paradigms such as patient journey, HCP behavior, source of business, among others
- Continuously monitor and assess market share evolution of Brand A and its competitors to evaluate impact of market events
2
Approach
- Created and differentiated patient and prescriber profiles for Brand A vs. those of competitors
- Studied and quantified the reasons for prescription as well as shift of therapy between Brand A and its competitors
- Identified and tracked the key parameters affecting treatment decision at the point of prescription
3
Outcome
- Key differentiating features were identified and validated over multiple patient and prescriber cycles
- Source of business and rationale for treatment choice for Brand A and its competitors were identified from both patient and prescriber data sources and ranked by importance
- A standard templatized Brand A report was created to highlight key insights from the analysis of the patient and prescriber profiles
4
Client Benefits
- The analysis provided targeted insights into the second line rare hematological indication prescribing habits and enabled the brand team to identify potential opportunities that could provide an edge over the competitors
- The client team gained an in-depth understanding of the profile of physicians who can be potential future prescribers
- Detailed and validated understanding was provided to the client with respect to the factors impacting the treatment decisions at point of prescription. This analysis impacting the treatment decisions at point of prescription was included in the routine chart audit tracking to gauge the impact of market dynamics